Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)
Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –
Stryker Neuro Cranial by Quarter
Neuro Cranial (Legacy Standalone through FY2025Q4) — Worldwide CC Growth YoY (%) (%)
Stryker Neuro Cranial: 10.2% in Q4 2025, down 5.6 pts from a year earlier.
Latest, Q4 2025
10.2%
Period ended Dec 31, 2025
Change on a year earlier
-5.6 pts
15.8% in Q4 2024
History
17 quarters
Since Q4 2021
Sources
17
Documents cited below
Where the Q4 2025 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Neuro Cranial (%), quarterly Q4 2021–Q4 2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/leg-nc-ww-cc
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?